The virus inoculum volume influences outcome of influenza A infection in mice

Laboratory Animals

Volumn 47, Issue 1, 2013, Pages 74-77

  Miller, Darren S ^a   Kok, Tuckweng ^a,b   Li, Peng ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Dose delivery refinement; Influenza A; Mouse model; Respiratory distress; Volume dependent outcomes

Indexed keywords

VIRUS RNA;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; FLUID INTAKE; FOOD INTAKE; INFLUENZA A; INFLUENZA VIRUS A; INOCULATION; MOUSE; NONHUMAN; PRACTICE GUIDELINE; TEMPERAMENT; UPPER RESPIRATORY TRACT; WEIGHT REDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS; LABORATORY ANIMAL SCIENCE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RESEARCH DESIGN; RODENT DISEASES;

EID: 84878049682     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2012.011157     Document Type: Article

References (22)

1. Tumpey TM, Szretter KJ, Van Hoeven N, et al. The Mx1 gene protects mice against pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 2007;81:10818-21
2. Belser JA, Lu X, Maines TR, et al. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulenceof Eurasian H7N7 viruses isolated from humans. J Virol 2007;81:11139-47
3. Johansson BE, Kilbourne ED. Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection. J Virol Methods 1991;35:109-14
4. Nagata T, Toyota T, Ishigaki H, et al. Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses. Vaccine 2007;25:4914-21
5. Ko SY, Ko HJ, Chang WS, et al. Alpha-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 2005;175:3309-17
6. Tamura S, Asanuma H, Ito Y, et al. Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. Vaccine 1994;12:310-16
7. Renegar KB, Small PA Jr, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004;173:1978-86
8. Hirabayashi Y, Kurata H, Funato H, et al. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990;8:243-8
9. Tsurita M, Kurokawa M, Imakita M, et al. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharmacol Exp Ther 2001;298:362-8
10. Ibricevic A, Pekosz A, Walter MJ, et al. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 2006;80:7469-80
11. Arulanandam BP, O'Toole M, Metzger DW. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis 1999;180:940-9
12. Gao P, Watanabe S, Ito T, et al. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 1999;73:3184-9
13. Bracci L, Canini I, Puzelli S, et al. Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. Vaccine 2005;23:2994-3004
14. Lu X, Tumpey TM, Morken T, et al. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999;73:5903-11
15. Miller D, Finnie J, Bowden T, et al. Preclinical efficacy studies of influenza A haemagglutinin precursor loop peptides as a potential vaccine. J Gen Virol 2011;92(Pt 5): 1152-61
16. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hygiene 1938;27:493-7
17. Stone B, Burrows J, Schepetiuk S, et al. Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR. J Virol Methods 2004;117:103-12
18. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997;51:311-40
19. Reznik GK. Comparative anatomy, physiology, and function of the upper respiratory tract. Environ Health Perspect 1990;85:171-6
20. Bomsel M, Alfsen A. Entry of viruses through the epithelial barrier: pathogenic trickery. Nat Rev Mol Cell Biol 2003;4:57-68
21. Liu C, Wong E, Miller D, et al. Lentiviral airway gene transfer in lungs of mice and sheep: successes and challenges. J Gene Med 2010;12:647-58
22. Southam DS, Dolovich M, O'Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 2002;282:L833-839